Integra LifeSciences Holdings

Healthcare · Medical Devices

13.00$ -2.4% vs. previous close Closing price · As of: Oct 7, 2026

Statements

Balance Sheet

Integra LifeSciences Holdings (IART) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 3,586 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size %

Last 12 Full history

Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet IART
Line item	Q3 16	Q4 16	Q1 17	Q2 17	Q3 17	Q4 17	Q1 18	Q2 18	Q3 18	Q4 18	Q1 19	Q2 19	Q3 19	Q4 19	Q1 20	Q2 20	Q3 20	Q4 20	Q1 21	Q2 21	Q3 21	Q4 21	Q1 22	Q2 22	Q3 22	Q4 22	Q1 23	Q2 23	Q3 23	Q4 23	Q1 24	Q2 24	Q3 24	Q4 24	Q1 25	Q2 25	Q3 25	Q4 25	Q1 26	Q2 26
Total Assets	1,827	1,808	2,049	2,101	2,418	3,211	3,248	3,186	3,179	3,108	3,206	3,290	3,347	3,303	3,448	3,392	3,454	3,615	3,742	3,713	3,774	3,782	3,672	3,753	3,807	3,890	3,742	3,778	3,739	3,782	4,078	4,074	4,066	4,037	971	3,668	3,646	3,602	3,578	3,586
Current Assets	512	495	569	616	945	822	849	821	828	775	823	869	884	858	1,009	966	1,152	1,237	1,039	1,032	1,104	1,154	1,066	1,137	1,196	1,161	1,029	1,051	1,027	1,058	1,416	1,112	1,100	1,082	971	1,143	1,144	1,160	1,172	1,180
Cash	108	102	124	155	482	175	189	184	206	139	157	176	208	199	358	361	396	470	409	397	470	513	407	447	512	457	307	309	274	276	592	215	215	246	239	218	232	235	237	214
Cash & Short-Term Investments	108	102	135	155	482	175	189	184	206	139	157	176	208	199	358	361	396	470	409	397	470	513	407	447	512	457	307	309	274	309	663	297	278	274	273	254	268	264	266	274
Receivables	141	148	158	171	171	252	272	258	249	266	279	297	281	275	253	179	225	226	230	238	231	243	246	237	248	263	254	259	267	259	241	278	248	272	252	285	262	279	264	267
Inventory	220	217	240	235	232	296	290	291	291	280	287	297	303	316	338	359	308	310	328	324	327	317	328	320	311	325	351	354	366	390	403	422	437	429	445	465	489	493	495	492
Property, Plant & Equipment	212	222	229	232	232	269	274	277	287	300	306	316	319	337	336	334	294	288	296	385	294	312	309	302	301	311	315	318	–	–	–	–	–	–	–	–	–	–	–	–
Goodwill	516	511	578	585	588	938	944	927	926	926	923	927	945	954	952	956	920	932	1,010	1,016	1,012	1,013	1,009	990	978	1,039	1,042	1,043	1,036	1,055	1,040	1,105	1,117	1,097	1,105	616	615	615	613	613
Intangible Assets	574	561	654	649	634	1,160	1,148	1,122	1,097	1,079	1,059	1,042	1,040	1,032	1,014	999	974	989	1,194	1,179	1,156	1,146	1,122	1,082	1,054	1,127	1,109	1,094	1,067	1,068	1,023	1,220	1,210	1,208	1,188	1,188	1,160	1,135	1,105	1,105
Total Liabilities	1,004	968	1,197	1,207	1,505	2,249	1,832	1,844	1,432	1,732	1,809	1,869	1,962	1,887	2,106	2,043	2,056	2,100	2,212	2,138	2,143	2,098	2,057	2,092	2,083	2,085	2,067	2,094	2,160	2,194	2,480	2,540	2,544	2,492	2,529	2,629	2,609	2,559	2,535	2,535
Current Liabilities	161	124	188	178	210	349	336	233	258	263	288	315	303	331	246	212	255	401	412	319	333	340	316	296	304	321	282	377	356	307	302	328	913	922	918	930	364	456	347	347
Short-Term Debt	29	665	6.3	13	19	60	60	1,476	11	23	46	72	69	70	13	38	35	159	170	80	80	75	74	76	83	67	15	110	101	30	36	39	617	622	627	628	53	141	53	53
Accounts Payable	39	29	46	42	41	94	87	84	86	76	101	107	94	113	97	58	50	55	62	66	60	62	88	69	81	102	113	100	94	92	94	107	78	83	91	93	92	96	88	88
Long-Term Debt	659	665	849	868	1,153	1,781	1,772	1,476	1,421	1,211	1,205	1,205	1,274	1,199	1,478	1,472	1,414	1,408	1,485	1,499	1,387	1,389	1,390	1,386	1,381	1,300	1,337	1,333	1,420	1,485	1,837	1,801	1,205	1,196	1,231	1,227	1,792	1,730	1,827	1,829
Shareholders' Equity	823	840	852	895	913	962	998	1,342	1,365	1,376	1,397	1,421	1,385	1,417	1,342	1,349	1,398	1,515	1,529	1,575	1,632	1,685	1,615	1,661	1,724	1,804	1,675	1,683	1,579	1,588	1,598	1,534	1,522	1,545	1,524	1,039	1,038	1,043	1,042	1,051
Retained Earnings	192	220	227	238	241	285	298	310	323	348	381	411	383	399	408	407	440	532	575	610	653	699	731	776	826	879	903	908	927	947	944	931	920	940	915	431	425	423	419	427
Shares Outstanding	81	80	78	79	79	80	80	84	86	87	86	86	86	87	86	85	85	85	85	85	85	86	84	84	83	84	82	81	80	78	78	77	76	77	76	76	77	77	77	78

Showing the most recent 40 periods — older statements are on file for this stock.

Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?

Balance Sheet

Cookie settings